Introduction
============

Lung cancer is the most commonly diagnosed cancer as well as the leading cause of cancer death in males globally, with 1.6 million newly confirmed cases and 1.4 million deaths from lung cancer annually.[@b1-ott-8-1611] In the last decade, the incidence and mortality rates of lung cancer in the People's Republic of China have increased significantly and constantly.[@b1-ott-8-1611] It was estimated that 605,946 lung cancer cases were diagnosed in 2010 in the People's Republic of China, with a crude incidence rate of 46.08/100,000, and 486,555 patients died from lung cancer, with a crude mortality rate of 37.00/100,000.[@b2-ott-8-1611] Although risk of lung cancer has been conclusively associated with tobacco smoking,[@b3-ott-8-1611] fewer than 20% of smokers develop the disease, indicating that genetic variations and other environmental factors may play important roles in the development of lung cancer.[@b4-ott-8-1611],[@b5-ott-8-1611] In recent years, the impact of inherited polymorphisms in the cytochrome P450 1A1 (CYP1A1) gene on susceptibility to lung cancer has received particular interest since this enzyme plays an essential role in the metabolic activation of major classes of tobacco procarcinogen such as aromatic amines and polycyclic aromatic hydrocarbons. The CYP1A1 exon 7 polymorphism, resulting in the substitution of isoleucine with valine (Ile462Val) (National Center for Biotechnology Information single-nucleotide polymorphism identifier rs1048943; adenine \[A\] to guanine \[G\] substitution at nucleotide 2455 \[A2455G\]), is one of the most extensively studied genes in lung cancer susceptibility. An association between CYP1A1 exon 7 polymorphism and lung cancer was first reported by Nakachi et al in 1993 among the Japanese population,[@b6-ott-8-1611] after which many studies analyzed the influence of CYP1A1 exon 7 polymorphism on lung cancer risk; no clear consensus, however, was reached. Meta-analyses of studies on the gene in other ethnic groups have been reported elsewhere and produced conflicting results.[@b7-ott-8-1611]--[@b12-ott-8-1611] In order to lessen the impact of different genetic backgrounds, we performed this updated meta-analysis to assess the relationship of CYP1A1 exon 7 polymorphism with risk of lung cancer in the Chinese population.

Materials and methods
=====================

Search strategy and selection criteria
--------------------------------------

We systematically searched the PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biology Medicine (CBM) databases for studies published before October 10, 2014, using the following MeSH terms: ("Lung Neoplasms" \[MeSH\] or "lung cancer" or "lung tumor" or "lung carcinoma" or "carcinoma of lung") and ("cytochrome P450 1A1" or "CYP1A1") and ("China" or "Chinese" or "Taiwan"). The search was performed without any restrictions on language and focused on studies conducted in humans. Additional studies were identified by handsearching references in original research articles and review articles. Studies were selected according to the following criteria: 1) case--control study or cohort study studying on association between the CYP1A1 exon 7 polymorphism and lung cancer susceptibility; 2) all patients with the diagnosis of lung cancer confirmed by pathological or histological examination; 3) sufficient published data about sample size, odds ratio (OR), and their 95% confidence interval (CI); 4) all participants were Chinese; and 5) in the case of duplication with multiple articles publishing data on the same population, the most complete dataset was included. Review papers, letters, case reports, or editorial articles were excluded.

Data extraction
---------------

Information was carefully extracted from all eligible publications independently by the two authors according to the inclusion criteria. Disagreements were resolved through a discussion between the two authors. The title and abstract of all potentially relevant articles were screened to determine their relevance. Full articles were also scrutinized if the title and abstract were ambiguous. The following data were collected from each study: first author's surname, year of publication, geographical location, ethnicity of subjects, source of controls, total numbers of cases and controls, genotype frequencies, and Hardy--Weinberg equilibrium test. Ethnicities were categorized as Han and other ethnic Chinese. We did not define any minimum number of patients to include a study in our meta-analysis. For articles including different ethnicities or areas, data were extracted separately.

Statistical analysis
--------------------

The ORs with 95% CIs were used to determine the strength of association between the CYP1A1 exon 7 polymorphisms and lung cancer risk. The pooled ORs were performed for allele model (G versus A), dominant model (GG + AG versus AA), recessive model (GG versus AG + AA), heterozygous model (GG versus AG), and homozygous model (GG versus AA), respectively. The distributions of genotypes in controls were tested by Hardy--Weinberg equilibrium using the *χ*^2^ test. Heterogeneity assumptions were assessed by *χ*^2^-based *Q*-test. A *P*-value greater than 0.10 for the *Q*-test indicated a lack of heterogeneity among the studies. Thus, the pooled OR estimate of each study was calculated using either the fixed-effects model (the Mantel--Haenszel method) or the random-effects model (the DerSimonian and Laird method). The significance of the pooled OR was determined by the *z*-test. Sensitivity analysis was conducted to verify stability of the meta-analysis using both models (the fixed-effects and random-effects). Potential publication biases were estimated by funnel plot, in which the standard error of log OR of each study was plotted against its log OR. An asymmetrical plot suggests a publication bias. Funnel plot asymmetry was assessed by Egger's linear regression test, a linear regression approach that measures the funnel plot asymmetry on a natural logarithm scale of the OR. The significance of the intercept was determined by *t*-test, as suggested by Egger[@b13-ott-8-1611] (*P*\<0.05 was considered a statistically significant publication bias). In addition, subgroup analysis stratified by ethnicity, source of controls, and geographical locations was also performed. All the statistical analyses were performed using the STATA statistical package (version 10; StataCorp LP, College Station, TX, USA).

Results
=======

Eligible studies
----------------

According to the inclusion criteria, 25 case--control studies[@b14-ott-8-1611]--[@b38-ott-8-1611] were included and 163 articles were excluded. The publication year of included studies ranged from 1998 to 2014. A flowchart of the study selection process is shown in [Figure 1](#f1-ott-8-1611){ref-type="fig"}. In total, 3,540 lung cancer cases and 5,284 controls were involved in this meta-analysis, which evaluated the relationship between CYP1A1 exon 7 polymorphism and lung cancer risk. The source of controls was mainly based on a healthy population. Fifteen of these studies were written in Chinese, and ten studies were in English. The characteristics of the included studies are summarized in [Table 1](#t1-ott-8-1611){ref-type="table"}.

Quantitative synthesis
----------------------

[Table 2](#t2-ott-8-1611){ref-type="table"} lists the primary results. Overall, a significantly elevated risk of lung cancer was associated with all variants of CYP1A1 exon 7 (G versus A: OR = 1.30, 95% CI: 1.17--1.45; GG versus AA: OR = 1.71, 95% CI: 1.46--2.01; GG versus AG: OR = 1.41, 95% CI: 1.21--1.64; GG + AG versus AA: OR = 1.37, 95% CI: 1.16--1.62; GG versus AA + AG: OR = 1.52, 95% CI: 1.32--1.76) ([Figure 2](#f2-ott-8-1611){ref-type="fig"}). However, there was significant heterogeneity between some models. Hence, we then performed subgroup analysis by geographical locations, ethnicity, and source of controls. In the stratified analysis by geographical locations, significantly increased risk was found both in North China (G versus A: OR = 1.28, 95% CI: 1.13--1.46; GG versus AA: OR = 1.60, 95% CI: 1.33--1.91; GG versus AG: OR = 1.31, 95% CI: 1.10--1.55; GG + AG versus AA: OR = 1.41, 95% CI: 1.15--1.73; GG versus AA + AG: OR = 1.41, 95% CI: 1.20--1.65) and South China (G versus A: OR = 1.39, 95% CI: 1.10--1.76; GG versus AA: OR = 2.13, 95% CI: 1.51--3.01; GG versus AG: OR = 1.80, 95% CI: 1.26--2.58; GG versus AA + AG: OR = 2.01, 95% CI: 1.44--2.81). In the stratified analysis by source of controls, significantly increased risk was found both in the population-based studies (G versus A: OR = 1.32, 95% CI: 1.15--1.50; GG versus AA: OR = 1.77, 95% CI: 1.36--2.31; GG versus AG: OR = 1.38, 95% CI: 1.15--1.66; GG + AG versus AA: OR = 1.40, 95% CI: 1.15--1.71; GG versus 1G: OR = 1.49, 95% CI: 1.25--1.77) and hospital-based studies (G versus A: OR = 1.29, 95% CI: 1.13--1.47; GG versus AA: OR = 2.05, 95% CI: 1.50--2.79; GG versus AG: OR = 1.44, 95% CI: 1.10--1.88; GG + AG versus AA: OR = 1.39, 95% CI: 1.13--1.72; GG versus AA + AG: OR = 1.59, 95% CI: 1.23--2.06). In the subgroup analysis by ethnicity, significantly increased association was found in Chinese Han people (GG versus AA: OR =1.59, 95% CI: 1.11--2.30; GG versus AG: OR = 1.38, 95% CI: 1.12--1.68; GG versus AA + AG: OR = 1.40, 95% CI: 1.16--1.70).

Sensitivity analysis and bias diagnosis
---------------------------------------

In order to compare the difference and evaluate the sensitivity of the meta-analysis, we used both models (fixed-effects and random-effects) to evaluate the stability of the meta-analysis. None of the results were materially altered ([Table 2](#t2-ott-8-1611){ref-type="table"}). Hence, the results of the sensitivity analysis suggest that the data in this meta-analysis are relatively stable and credible. Begg's funnel plot and Egger's test were performed to assess publication bias. The shape of the funnel plots did not reveal obvious asymmetry ([Figure 3A](#f3-ott-8-1611){ref-type="fig"}). Subsequently, the Egger's test was used to provide statistical evidence of funnel plot symmetry. The Egger's test indicated that there was no obvious publication bias under the allele model in overall analysis ([Figure 3B](#f3-ott-8-1611){ref-type="fig"}) (*t*=2.09, *P*=0.058).

Discussion
==========

Cytochrome P450 genes are large families of endoplasmic and cytosolic enzymes that catalyze the activation and detoxification, respectively, of reactive electrophilic compounds, including many environmental carcinogens (eg, benzo\[a\]pyrene). CYP1A1 is a phase I enzyme that regulates the metabolic activation of major classes of tobacco procarcinogens, such as aromatic amines and polycyclic aromatic hydrocarbons.[@b39-ott-8-1611] Thus, CYP1A1 may affect the metabolism of environmental carcinogens and alter the susceptibility to lung cancer. Although many studies have analyzed the CYP1A1 exon 7 polymorphism and its association with lung cancer, definitive conclusions cannot be drawn. Therefore, we performed the current meta-analysis to estimate the relationship between CYP1A1 exon 7 polymorphism and susceptibility to lung cancer among the Chinese population only, in order to lessen the impact of different genetic backgrounds. The meta-analysis involved 25 articles including 3,540 lung cancer cases and 5,284 controls. The results showed that the variant genotypes of the CYP1A1 exon 7 polymorphism were significantly associated with lung cancer risk in the Chinese population. Our results were consistent with a previously published meta-analysis in Chinese populations,[@b40-ott-8-1611] which found that, compared with the wild-type homozygous genotype (AA), lung cancer risk for the combined variant genotypes (GG and AG) was 1.61-fold (95% CI: 1.24--2.08) (*Z*=3.62, *P*\<0.001). However, this previously published meta-analysis did not search some other databases in the People's Republic of China (Wanfang Data Knowledge Service Platform and CBM), and included a smaller number of studies than ours did.

The effects of genetic polymorphisms on cancer risk seem to be affected by ethnic background. Several studies have shown that the CYP1A1 exon 7 polymorphism is associated with an increased lung cancer risk in the Asian population.[@b7-ott-8-1611]--[@b9-ott-8-1611] However, previous research, including some pooled analyses, suggest that there is not an established association between this polymorphism and increased lung cancer risk in Caucasian populations.[@b10-ott-8-1611],[@b41-ott-8-1611] Therefore, we performed the subgroup analyses by ethnicity, source of controls, and geographical locations. The results revealed that significant association with susceptibility to the development of lung cancer was found in Chinese Han people, in population-based studies, in hospital-based studies, in South China, and in North China. The ethnic differences might be ascribed to genetic backgrounds and the gene--environment interactions in the etiology. In addition, the CYP1A1 exon 7 variant genotype has a high prevalence among Asians compared with Caucasians and African--Americans.

The pathways of carcinogen metabolism are complex, mediated by the activity of multiple enzymes. The effect of any single gene might have a more limited impact than has so far been anticipated. Lung cancer has some known major environmental determinants other than tobacco smoke, and large studies with detailed exposure information are needed to evaluate reliably any moderate genetic effects. Otherwise, some limitations should be acknowledged. First, we did not perform subgroup analysis on smoking status, because of the lack of sufficient data. Second, our results were based on unadjusted estimates. More precise analyses can be conducted if individual data were available, which would allow for the adjustment by other covariates including age, sex, location, race, and other factors. Final, heterogeneity is a potential problem when interpreting the results of meta-analysis. As significant between-study heterogeneity existed in a few comparisons, the results from meta-analysis should be interpreted with an appropriate degree of caution. In spite of these limitations, our meta-analysis still had some advantages. Most of all, we obeyed the inclusion and exclusion criteria strictly to reduce selection bias. Besides, our inclusion of non-English-language reports was important in minimizing a major potential threat to the validity of any meta-analysis publication bias and the related threat of a language bias. Last but not least, there was no evidence of publication bias in this meta-analysis and the sensitivity analysis confirmed the reliability and stability of the results. Therefore, the 25 studies would appear to be comparable in all respects relevant to our meta-analysis.

Conclusion
==========

Our meta-analysis supports that CYP1A1 exon 7 polymorphism might contribute to individual susceptibility to lung cancer in Chinese. Concerning lung cancer with multifactorial etiology, to further evaluate gene--gene and gene--environment interactions on CYP1A1 exon 7 and lung cancer, larger studies in selected populations with different environmental backgrounds or other risk factors are required. Such studies may eventually lead to a better, comprehensive understanding of the association between the CYP1A1 exon 7 and lung cancer risk.
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![Forest plot (random-effects model) of lung cancer risk associated with CYP1A1 MspI polymorphism using the allele genetic model.\
**Note:** Weights are from random-effects analysis.\
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**Notes:** (**A**) Begg's funnel plot. (**B**) Egger's test.\
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###### 

Characteristics of studies included in the meta-analysis

  Study                            Source of controls   Area             Ethnicity    Number of cases   Number of controls   Case   Control   HWE                             
  -------------------------------- -------------------- ---------------- ------------ ----------------- -------------------- ------ --------- ----- ----- ----- ---- -------- -------
  Hu and Zhang[@b14-ott-8-1611]    PB + HB              Guangdong        Han          59                132                  19     33        7     21    102   9    41.12    0.000
  Qu et al[@b15-ott-8-1611]        PB                   Shanghai         Not stated   100               95                   56     36        8     56    35    4    0.26     0.612
  Qu et al[@b15-ott-8-1611]        PB                   Heilongjiang     Not stated   80                87                   42     36        2     52    32    3    0.52     0.470
  Chen et al[@b16-ott-8-1611]      PB                   Jiangsu          Not stated   68                105                  35     21        12    66    30    9    3.78     0.052
  Persson et al[@b17-ott-8-1611]   PB                   Beijing          Not stated   76                119                  50     20        6     77    37    5    0.04     0.835
  Song et al[@b18-ott-8-1611]      PB                   Beijing          Not stated   150               391                  53     90        7     200   178   13   12.74    0.000
  London et al[@b19-ott-8-1611]    PB                   Shanghai         Not stated   214               669                  167    39        8     512   130   27   21.86    0.000
  Song et al[@b20-ott-8-1611]      PB                   Beijing          Not stated   217               404                  78     130       9     210   181   13   12.45    0.000
  Zhang et al[@b21-ott-8-1611]     HB                   Jiangsu          Not stated   40                30                   17     13        10    18    10    2    0.14     0.708
  Chen et al[@b22-ott-8-1611]      PB                   Jiangsu          Not stated   106               106                  58     38        10    70    33    3    0.14     0.704
  Zhou et al[@b23-ott-8-1611]      HB                   Hubei            Not stated   92                98                   15     66        11    27    65    6    14.93    0.000
  Zhang et al[@b24-ott-8-1611]     HB                   Jiangsu          Not stated   65                60                   24     29        12    32    23    5    0.09     0.765
  Dong et al[@b25-ott-8-1611]      HB                   Sichuan          Not stated   82                91                   28     36        18    49    32    10   1.74     0.187
  Yang et al[@b26-ott-8-1611]      PB                   Liaoning         Not stated   197               144                  90     96        11    98    39    7    0.82     0.239
  Ng et al[@b27-ott-8-1611]        HB                   Singapore        Not stated   126               161                  74     39        13    91    63    7    0.91     0.339
  Liu et al[@b28-ott-8-1611]       PB                   Shandong         Han          110               125                  18     80        12    35    83    7    19.820   0.000
  Song et al[@b29-ott-8-1611]      PB                   Shandong         Han          125               125                  20     90        15    36    80    9    14.68    0.000
  Zhou et al[@b30-ott-8-1611]      PB                   Henan            Not stated   209               208                  39     135       35    55    128   25   13.73    0.000
  Wang et al[@b31-ott-8-1611]      PB                   Liaoning         Han          72                90                   37     9         26    54    25    11   7.06     0.008
  Bai et al[@b32-ott-8-1611]       HB                   Inner Mongolia   Han          106               250                  25     66        15    54    172   24   39.22    0.000
  Wang et al[@b33-ott-8-1611]      PB                   Henan            Han          209               256                  95     66        48    148   70    38   27.76    0.000
  Lv et al[@b34-ott-8-1611]        HB                   Inner Mongolia   Han          116               216                  17     75        24    44    133   39   11.64    0.001
  Liu et al[@b35-ott-8-1611]       HB                   Inner Mongolia   Han          174               324                  26     112       36    66    200   58   17.94    0.000
  He et al[@b36-ott-8-1611]        PB                   Hebei            Han          275               406                  141    103       31    165   183   58   0.40     0.529
  Jiang et al[@b37-ott-8-1611]     PB                   Inner Mongolia   Mongolian    142               190                  18     101       23    28    136   26   35.42    0.000
  Jiang et al[@b37-ott-8-1611]     PB                   Inner Mongolia   Han          180               266                  42     112       26    57    183   26   41.48    0.000
  Yang et al[@b38-ott-8-1611]      PB                   Hebei            Not stated   150               136                  52     75        23    61    65    10   1.72     0.190

**Abbreviations:** HB, hospital-based; HWE, Hardy--Weinberg equilibrium; PB, population-based.

###### 

Main results in the total and subgroup analysis

  Analysis model      Study groups     n                   Random-effects model   Fixed-effects model   Heterogeneity   
  ------------------- ---------------- ------------------- ---------------------- --------------------- --------------- -------
  G versus A          Total analysis   27                  1.30 (1.17--1.45)      1.26 (1.18--1.35)     61.48           0.000
  PB                  18               1.32 (1.15--1.50)   1.27 (1.17--1.37)      46.80                 0.000           
  HB                  8                1.32 (1.12--1.56)   1.29 (1.13--1.47)      10.36                 0.169           
  Chinese Han         10               1.18 (0.98--1.42)   1.13 (1.03--1.25)      31.77                 0.000           
  South China         9                1.39 (1.10--1.76)   1.32 (1.14--1.53)      18.47                 0.018           
  North China         17               1.28 (1.13--1.46)   1.25 (1.16--1.35)      42.07                 0.000           
  GG versus AA        Total analysis   27                  1.81 (1.48--2.22)      1.71 (1.46--2.01)     37.36           0.069
  PB                  18               1.77 (1.36--2.31)   1.63 (1.35--1.97)      29.23                 0.032           
  HB                  8                2.02 (1.48--2.77)   2.05 (1.50--2.79)      5.54                  0.595           
  Chinese Han         10               1.59 (1.11--2.30)   1.46 (1.17--1.81)      22.29                 0.008           
  South China         9                2.18 (1.43--3.33)   2.13 (1.51--3.01)      10.47                 0.233           
  North China         17               1.69 (1.33--2.15)   1.60 (1.33--1.91)      24.78                 0.074           
  GG versus AG        Total analysis   27                  1.40 (1.20--1.64)      1.41 (1.21--1.64)     26.21           0.452
  PB                  18               1.38 (1.13--1.70)   1.38 (1.15--1.66)      19.24                 0.315           
  HB                  8                1.43 (1.09--1.87)   1.44 (1.10--1.88)      5.90                  0.552           
  Chinese Han         10               1.45 (1.11--1.89)   1.38 (1.12--1.68)      14.14                 0.118           
  South China         9                1.79 (1.24--2.58)   1.80 (1.26--2.58)      3.43                  0.905           
  North China         17               1.31 (1.09--1.58)   1.31 (1.10--1.55)      18.08                 0.319           
  GG + AG versus AA   Total analysis   27                  1.37 (1.16--1.62)      1.33 (1.21--1.47)     73.01           0.000
  PB                  18               1.40 (1.15--1.71)   1.35 (1.22--1.51)      51.52                 0.000           
  HB                  8                1.43 (1.10--1.87)   1.39 (1.13--1.72)      10.40                 0.167           
  Chinese Han         10               1.16 (0.84--1.59)   1.10 (0.94--1.27)      35.24                 0.000           
  South China         9                1.35 (0.97--1.89)   1.28 (1.05--1.55)      21.40                 0.006           
  North China         17               1.41 (1.15--1.73)   1.38 (1.24--1.55)      48.58                 0.000           
  GG versus AA + AG   Total analysis   27                  1.54 (1.32--1.80)      1.52 (1.32--1.76)     28.79           0.321
  PB                  18               1.53 (1.24--1.88)   1.49 (1.25--1.77)      21.82                 0.192           
  HB                  8                1.57 (1.20--2.03)   1.59 (1.23--2.06)      6.73                  0.458           
  Chinese Han         10               1.49 (1.13--1.95)   1.40 (1.16--1.70)      16.29                 0.061           
  South China         9                1.99 (1.41--2.80)   2.01 (1.44--2.81)      5.72                  0.678           
  North China         17               1.42 (1.19--1.71)   1.41 (1.20--1.65)      18.74                 0.283           

**Notes:** South China including Guangdong, Shanghai, Jiangsu, Hubei, and Sichuan; North China including Heilongjiang, Beijing, Liaoning, Inner Mongolia, Hebei, Shandong, and Henan.

**Abbreviations:** CI, confidence interval; HB, hospital-based; OR, odds ratio; PB, population-based.
